Within the tumor microenvironment, TAMs are identified as alternatively activated (M2) macrophages, which are characterized by poor capability to present antigen, distinctive expression of cytokines and chemokines, such as interleukin (IL)-10, CCL17, CCL22, and TGF-β [3–5]. The gene discussed is TGFB1; the disease is neoplasm.